These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Bleeding in Neurosurgical Patients: A Single-Center Experience. Mačiukaitienė J; Bilskienė D; Tamašauskas A; Bunevičius A Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344253 [No Abstract] [Full Text] [Related]
12. Safety and effectiveness of a prothrombin complex concentrate in approved and off-label indications. Marcos-Jubilar M; García Erce JA; Martínez-Calle N; Páramo JA; Martínez Virto A; Quintana-Díaz M Transfus Med; 2019 Aug; 29(4):268-274. PubMed ID: 31347218 [TBL] [Abstract][Full Text] [Related]
13. Rapid response to intravenous vitamin K may obviate the need to transfuse prothrombin complex concentrates. Sahai T; Tavares MF; Sweeney JD Transfusion; 2017 Aug; 57(8):1885-1890. PubMed ID: 28543073 [TBL] [Abstract][Full Text] [Related]
14. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication. Yasaka M; Sakata T; Minematsu K; Naritomi H Thromb Res; 2002 Oct; 108(1):25-30. PubMed ID: 12586128 [TBL] [Abstract][Full Text] [Related]
15. Prothrombin complex concentrate accelerates international normalized ratio reversal and diminishes the extension of intracranial hemorrhage in geriatric trauma patients. Edavettal M; Rogers A; Rogers F; Horst M; Leng W Am Surg; 2014 Apr; 80(4):372-6. PubMed ID: 24887668 [TBL] [Abstract][Full Text] [Related]
16. Mortality in vitamin K antagonist-related intracerebral bleeding treated with plasma or 4-factor prothrombin complex concentrate. Majeed A; Meijer K; Larrazabal R; Arnberg F; Luijckx GJ; Roberts RS; Schulman S Thromb Haemost; 2014 Feb; 111(2):233-9. PubMed ID: 24154891 [TBL] [Abstract][Full Text] [Related]
17. Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study. Margraf DJ; Seaburg S; Beilman GJ; Wolfson J; Gipson JC; Chapman SA BMC Emerg Med; 2020 Nov; 20(1):93. PubMed ID: 33243152 [TBL] [Abstract][Full Text] [Related]
18. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate. Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122 [TBL] [Abstract][Full Text] [Related]
19. Reversal of Vitamin K Antagonist (VKA) effect in patients with severe bleeding: a French multicenter observational study (Optiplex) assessing the use of Prothrombin Complex Concentrate (PCC) in current clinical practice. Desmettre T; Dehours E; Samama CM; Jhundoo S; Pujeau F; Guillaudin C; Hecquart C; Clerson P; Crave JC; Jaussaud R Crit Care; 2012 Oct; 16(5):R185. PubMed ID: 23036234 [TBL] [Abstract][Full Text] [Related]
20. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy. Huynh TK; Costello JL; Rebuck JA Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]